Clinical Trial Update: APROVE : Irbesartan in Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for APROVE evaluating irbesartan in hypertension; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• AVAPRO (irbesartan)

Snippet

Sponsor: Sanofi | Conditions: Hypertension | Phase 4 | Status: COMPLETED